Ilya Pharma will present at the Swiss Nordic Bio 10-11 February 2021
FDA opened for 5 new endpoints in Nov 2020 (vs. only 1 until then) following thorough work by FDA’s Inter-center Wound Healing Work group and industry Wound Experts/FDA Clinical Endpoints Project.
Financing innovations in pharmaceutical development – facilitating the next stage of growth
High level operational report summarising key milestones Q2 2020 and forward looking statement.